COMPASS Pathways

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder	Stress Disorders, Traumatic, acute stress disorder, combat disorder, injury, post-traumatic stress disorder, psychiatric disorder	Recruiting	Phase 2 / Phase 3	2026-10-06	NCT07570654
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-08-13	NCT06247839
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD	Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder	Active, not recruiting	Phase 3	2026-08-10	NCT05711940
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Active, not recruiting	Phase 2	2025-08-19	NCT05733546

Clinical trials